Probiotic mixture supplementation in the preventive management of trinitrobenzenesulfonic acid-induced inflammation in a murine model

Journal of Biological Regulators and Homeostatic Agents

Volumn 30, Issue 3, 2016, Pages 895-901

  Traina, G ^a   Menchetti, L ^a   Rappa, F ^b   Casagrande Proietti, P ^a   Barbato, O ^a   Leonardi, L ^a   Carini, F ^b   Piro, F ^a   Brecchia, G ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

Disease activity index; IBD; Induced colitis model; Microbiota; Probiotics

Indexed keywords

ALCOHOL; PROBIOTIC AGENT; SODIUM CHLORIDE; TRINITROBENZENESULFONIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIFIDOBACTERIUM ANIMALIS; CONTROLLED STUDY; DISEASE ACTIVITY; DOSE RESPONSE; DRUG EFFICACY; EXPERIMENTAL COLITIS; HISTOPATHOLOGY; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; LACTOBACILLUS CASEI; MALE; MORTALITY; MOUSE; NONHUMAN; ANIMAL; CHEMICALLY INDUCED; COLITIS; COLON; DISEASE MODEL; EVALUATION STUDY; INFLAMMATORY BOWEL DISEASES; MICROBIOLOGY; OUTBRED STRAIN; PATHOLOGY;

ANIMALS; ANIMALS, OUTBRED STRAINS; BIFIDOBACTERIUM ANIMALIS; COLITIS; COLON; DISEASE MODELS, ANIMAL; GASTROINTESTINAL MICROBIOME; INFLAMMATORY BOWEL DISEASES; LACTOBACILLUS CASEI; MALE; MICE; PROBIOTICS; TRINITROBENZENESULFONIC ACID;

EID: 84996848229     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Manichanh C, Borruel N, Casellas F, Guarner F. The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol 2012; 9(10):599-608.
2. Backhed F, Ley RE, Sonnenburg J.L, Peterson D.A, Gordon JI. Host-bacterial mutualism in the human intestine. Science 2005; 307:1915-20.
3. Cui HH, Chen CL, Wang JD, et al. Effects of probiotic on intestinal mucosa of patients with ulcerative colitis. World J Gastroenterol 2004; 10(10):1521-5.
4. Guo S, Guo Y, Ergun A, Lu L, Walker WA, Ganguli K. Secreted metabolites of Bifidobacterium infantis and Lactobacillus acidophilus protect immature human enterocytes from IL-1β-induced inflammation: a transcription profiling analysis. PLoS One 2015; 10 (4):e0124549.
5. Bellavia M, Rappa F, Lo Bello M, et al. Lactobacillus casei and bifidobacterium lactis supplementation reduces tissue damage of intestinal mucosa and liver after 2, 4, 6-trinitrobenzenesulfonic acid treatment in mice. J Biol Regul Homeost Agents 2014; 28(2):251-61.
6. Strober W, Fuss IJ, Blumberg RS. The immunology of mucosal models of inflammation. Annu Rev Immunol 2002; 20:495-549.
7. Murano M, Maemura K, Hirata I, et al. Therapeutic effect of intracolonically administered nuclear factor kappa B (p65) antisense oligonucleotide on mouse dextran sulphate sodium (DSS)-induced colitis. Clin Exp Immunol 2000; 120(1):51-58.
8. McCafferty DM, Sihota E, Muscara M, Wallace JL, Sharkey KA, Kubes P. Spontaneously developing chronic colitis in IL-10/iNOS double-deficient mice. Am J Physiol. Gastrointest Liver Physiol 2000; 279(1): G90-99.
9. Fava F, Danese S. Intestinal microbiota in inflammatory bowel disease: friend of foe? World J Gastroenterol 2011; 17(5):557-66.
10. Mencarelli A, Distrutti E, Renga B, et al. Probiotics modulate intestinal expression of nuclear receptor and provide counter-regulatory signals to inflammationdriven adipose tissue activation. PLoS One 2011; 6(7):e22978.